Cargando…

Short and long-term effects of high-dose intravenous methylprednisolone pulse therapy on thyroid-associated ophthalmopathy

The majority of previous studies on high-dose intravenous methylprednisolone pulse (IVMP) therapy have observed the clinical conditions of patients prior to and following treatment without any long-term follow-up, and these studies have predominantly focused on combined treatment. The present prospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiaomei, Wang, Shu, Qin, Li, Qiang, Wei, Dahal, Mahesh, Fan, Ping, Gao, Shan, Shi, Bingyin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950155/ https://www.ncbi.nlm.nih.gov/pubmed/27446294 http://dx.doi.org/10.3892/etm.2016.3446

Ejemplares similares

Pulse dexamethasone therapy versus pulse methylprednisolone therapy for treatment of Graves's ophthalmopathy
por: Philip, Rajeev, et al.
Publicado: (2013)

Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
por: Lai, Kenneth K. H., et al.
Publicado: (2023)

Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy
por: Higashiyama, Tomoaki, et al.
Publicado: (2016)

Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?
por: Liu, Ping, et al.
Publicado: (2021)

Intravenous pulse methylprednisolone for the treatment of severe COVID-19
por: Patoulias, Dimitrios, et al.
Publicado: (2023)

Leptin receptor is a key gene involved in the immunopathogenesis of thyroid‐associated ophthalmopathy
por: Chen, Ziyi, et al.
Publicado: (2021)

Thyroid-associated Ophthalmopathy
por: Şahlı, Esra, et al.
Publicado: (2017)

Long-term follow-up of seven patients with ophthalmopathy not associated with thyroid autoimmunity: heterogeneity of autoimmune ophthalmopathy
por: McCorquodale, Tom, et al.
Publicado: (2012)

Liver Dysfunction Associated with Intravenous Methylprednisolone Pulse Therapy in Patients with Graves' Orbitopathy
por: Eguchi, Hiroyuki, et al.
Publicado: (2015)

High-dose intravenous methylprednisolone for the prophylactic treatment of cluster headache
por: Kawada, Sanami, et al.
Publicado: (2013)

Cytokines in Thyroid-Associated Ophthalmopathy
por: Zhang, Pengbo, et al.
Publicado: (2022)

Infantile hemangioendothelioma treated with high dose methylprednisolone pulse therapy.
por: Park, E. A., et al.
Publicado: (2001)

T2 Mapping with and without Fat-Suppression to Predict Treatment Response to Intravenous Glucocorticoid Therapy for Thyroid-Associated Ophthalmopathy
por: Zhai, Linhan, et al.
Publicado: (2022)

Hepatotoxicity after high‐dose intravenous methylprednisolone in multiple sclerosis patients
por: Hidalgo de la Cruz, Milagros, et al.
Publicado: (2017)

Is the treatment with pulses of methylprednisolone safe?
por: Bednarczuk, Tomasz, et al.
Publicado: (2013)

Safety Profile and Effects of Pulsed Methylprednisolone on Vital Signs in Thyroid Eye Disease
por: Yong, Kai-Ling, et al.
Publicado: (2015)

Intravenous Glucocorticoid Treatment for Korean Graves' Ophthalmopathy Patients
por: Ahn, Hwa Young, et al.
Publicado: (2020)

Recurrence of optic nerve neuropathy - a possible side effect of intravenous methylprednisolone pulses treatment
por: Trautsolt, Katarzyna, et al.
Publicado: (2013)

Life-threatening complications of high doses of intravenous methylprednisolone for treatment of Graves’ orbitopathy
por: Walasik-Szemplińska, Dorota, et al.
Publicado: (2019)

Low-Dose Intravenous Methylprednisolone in Remission Induction Therapy for ANCA-Associated Vasculitis
por: Floyd, Lauren, et al.
Publicado: (2023)

Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
por: Maeda, Kimihito, et al.
Publicado: (2008)

Effect of short-term, high-dose methylprednisolone on oxidative stress in children with acute immune thrombocytopenia
por: Cura, Musa, et al.
Publicado: (2016)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
por: Tabasum, Arshiya, et al.
Publicado: (2016)

The involvement of T cell pathogenesis in thyroid-associated ophthalmopathy
por: Huang, Yazhuo, et al.
Publicado: (2018)

Intraorbital Electroacupuncture Therapy for Thyroid-associated Ophthalmopathy
por: Zhou, Ling-Yun, et al.
Publicado: (2017)

Intraorbital Steroid Injection for Active Thyroid Ophthalmopathy
por: Bagheri, Abbas, et al.
Publicado: (2020)

Treating Thyroid Associated Ophthalmopathy in Pediatric Patients
por: Dong, Tianyu, et al.
Publicado: (2022)

Therapy of moderate-to-severe Graves’ orbitopathy with intravenous methylprednisolone pulses is not associated with loss of bone mineral density
por: Rymuza, Joanna, et al.
Publicado: (2018)

Severe Adult Still's Disease Complicated by Purtscher-Like Retinopathy Treated with Intravenous Pulse Methylprednisolone and Tocilizumab
por: Akiyama, Kaho, et al.
Publicado: (2021)

Decrease in Bone Formation and Bone Resorption during Intravenous Methylprednisolone Pulse Therapy in Patients with Graves’ Orbitopathy
por: Rymuza, Joanna, et al.
Publicado: (2022)

Corticosteroids in Moderate-To-Severe Graves’ Ophthalmopathy: Oral or Intravenous Therapy?
por: Penta, Laura, et al.
Publicado: (2019)

A COMPARISON OF PULSE METHYLPREDNISOLONE TO LOW-DOSE METHYLPREDNISOLONE IN CRITICALLY-ILL PATIENTS WITH SARS-COV-2 PNEUMONIA: RETROSPECTIVE, OBSERVATIONAL STUDY
por: Bidin, F.N., et al.
Publicado: (2023)

Predicting the early risk of ophthalmopathy in Graves’ disease patients using TCR repertoire
por: Wang, Yue, et al.
Publicado: (2020)

Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial
por: Roy, Ajitesh, et al.
Publicado: (2015)

Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial
por: Li, Yan, et al.
Publicado: (2022)

Use of Single- or Two-dose Pulse Methylprednisolone in the Treatment of Acute Immune Thrombocytopenic Purpura
por: Turhan, Ayşe Bozkurt, et al.
Publicado: (2018)

Pulse methylprednisolone in allergic bronchopulmonary aspergillosis exacerbations
por: Singh Sehgal, Inderpaul, et al.
Publicado: (2014)

Intravenous Methylprednisolone Pulse Therapy Versus Intravenous Immunoglobulin in the Prevention of Coronary Artery Disease in Children with Kawasaki Disease: A Randomized Controlled Trial
por: Aslani, Nahid, et al.
Publicado: (2022)

Outcome of thyroid associated ophthalmopathy treated by radiation therapy
por: Abboud, Mirna, et al.
Publicado: (2011)

Diagnosis, Follow-Up and Treatment Results in Thyroid Ophthalmopathy
por: Savku, Esra, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_nht8er91mmngf8au8e48hlohg0